ARCHIVES

Anastrozole Better Than Tamoxifen For HR+ Postmenopausal Breast Cancer, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 5 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Study Confirms Male Risk Factors For Breast Cancer

February 28, 2014

In Brief: Balch, Morton Head SSO; Schantz, Rosen Move To MSK; Old Directs US Branch Of Ludwig Inst.

May 10, 1991

Tempero, Johnson To Lead ASCO

March 28, 2003

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

June 30, 1978

Fy 1981 Budget Breakdown B Mechanism, Activity

February 1, 1980